Ascletis’ monkeypox pill receives IND approval from FDA | Tech Reddy
[ad_1] Ascletis Pharma’s monkeypox treatment has received approval from the US Food and Drug Administration (FDA) for a New Drug (IND) application. The FDA made its decision based on the available data, and Askletis can now proceed to a Phase 1b clinical trial to evaluate the safety, tolerability, efficacy and pharmacokinetics of the pill in … Read more